Bibliome.ai browser hg19
Search
About
Stats
FAQ
MSH6 c.3055A>C ;(p.I1019L)
Variant ID: 2-48028177-A-C
NM_000179.2(
MSH6
):c.3055A>C;(p.I1019L)
This variant was identified in 3 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction.
Nature Communications
Li, Shengli S; Yuan, Li L; Xu, Zhi-Yuan ZY; Xu, Jing-Li JL; Chen, Gui-Ping GP; Guan, Xiaoqing X; Pan, Guang-Zhao GZ; Hu, Can C; Dong, Jinyun J; Du, Yi-An YA; Yang, Li-Tao LT; Ni, Mao-Wei MW; Jiang, Rui-Bin RB; Zhu, Xiu X; Lv, Hang H; Xu, Han-Dong HD; Zhang, Sheng-Jie SJ; Qin, Jiang-Jiang JJ; Cheng, Xiang-Dong XD
Publication Date: 2023-02-11
Variant appearance in text: MSH6: 3055A>C; Ile1019Leu
PubMed Link:
36774361
Variant Present in the following documents:
41467_2023_36462_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page
A prognostic risk model for glioma patients by systematic evaluation of genomic variations.
Iscience
Zhang, Baifeng B; Wan, Weiqing W; Li, Zibo Z; Gao, Zhixian Z; Ji, Nan N; Xie, Jian J; Wang, Junmei J; Wang, Bin B; Lai-Wan Kwong, Dora D; Guan, Xinyuan X; Gao, Shengjie S; Zhao, Yuanli Y; Lu, Youyong Y; Zhang, Liwei L; Rodland, Karin D KD; Tsang, Shirley X SX
Publication Date: 2022-12-22
Variant appearance in text: MSH6: I1019L
PubMed Link:
36536675
Variant Present in the following documents:
mmc3.xls, sheet 1
View BVdb publication page
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.
Scientific Reports
Sitthideatphaiboon, Piyada P; Teerapakpinyo, Chinachote C; Korphaisarn, Krittiya K; Leelayuwatanakul, Nophol N; Pornpatrananrak, Nopporn N; Poungvarin, Naravat N; Chantranuwat, Poonchavist P; Shuangshoti, Shanop S; Aporntewan, Chatchawit C; Chintanapakdee, Wariya W; Sriuranpong, Virote V; Vinayanuwattikun, Chanida C
Publication Date: 2022-02-09
Variant appearance in text: MSH6: I1019L
PubMed Link:
35140316
Variant Present in the following documents:
41598_2022_6239_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.
Scientific Reports
Sitthideatphaiboon, Piyada P; Teerapakpinyo, Chinachote C; Korphaisarn, Krittiya K; Leelayuwatanakul, Nophol N; Pornpatrananrak, Nopporn N; Poungvarin, Naravat N; Chantranuwat, Poonchavist P; Shuangshoti, Shanop S; Aporntewan, Chatchawit C; Chintanapakdee, Wariya W; Sriuranpong, Virote V; Vinayanuwattikun, Chanida C
Publication Date: 2022-02-09
Variant appearance in text: MSH6: I1019L
PubMed Link:
35140316
Variant Present in the following documents:
41598_2022_6239_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page